Clinical Trials Logo

Behavior Change Interventions clinical trials

View clinical trials related to Behavior Change Interventions.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT04113213 Suspended - Clinical trials for Cardiovascular Diseases

Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health

P-PLAC 2
Start date: October 5, 2019
Phase: N/A
Study type: Interventional

Prescribing lifestyle changes to patients who are at risk of cardiovascular disease, may be an extremely cost effective mechanism of improving health for the individual themselves and the NHS. It is already proven that positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption can lower the risk of cardiovascular disease, as well as reduce the risk of all-cause mortality. P-PLAC2 (Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health) is a Phase II interventional study to determine the efficacy of a Lifestyle Prescription (LRx), from the viewpoint of patients and healthcare practitioners. The study uses a mixed methods design, and full study training and support will be provided to staff involved in the recruitment of patients, through to the behaviour change consultation, and end of study. If the study proves successful, a lifestyle prescription (LRx) could then be made available to support NHS staff throughout all disciplines (specifically those working with patients who are at risk of cardiovascular disease (CVD).